Jacques Gonella, Director at ANTARES PHARMA, INC. (ATRS), sold 86,776 shares at $2.70 ($234K) on 2018-06-05, disclosed to the SEC on 2018-06-07.
Open-market sale of $234k ATRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.70 | 23,129 | $62K | 26.7% |
| 2 | $2.70 | 23,129 | $62K | 26.7% |
| 3 | $2.70 | 20,259 | $55K | 23.3% |
| 4 | $2.70 | 20,259 | $55K | 23.3% |
| Total | $2.70 avg | 86,776 | $234K | 100% |
| Filing → |
| ATRS | SELL | 2018-08-15 | $306K | — | Filing → |
| ATRS | SELL | 2018-08-10 | $1.5M | — | Filing → |
| ATRS | SELL | 2018-06-20 | $2K | — | Filing → |